Remarkably, treatment with OGT inhibition in the presence of an IPF stimuli in IPF AOs led to a substantial reduction in aberrant basal cells, achieving levels comparable to those observed in control organoids (Figure 3M), highlighting its potential to address both epithelial cell loss and abnormal proliferation and activation associated with IPF. Here, OGT is linked to idiopathic pulmonary fibrosis.